Retirement Systems of Alabama Sells 1,671 Shares of Clorox Co (CLX)

Retirement Systems of Alabama cut its position in shares of Clorox Co (NYSE:CLX) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 166,868 shares of the company’s stock after selling 1,671 shares during the quarter. Retirement Systems of Alabama’s holdings in Clorox were worth $25,099,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CLX. Millennium Management LLC increased its position in shares of Clorox by 539.2% during the 1st quarter. Millennium Management LLC now owns 63,727 shares of the company’s stock valued at $8,483,000 after purchasing an additional 53,757 shares during the last quarter. CIBC World Markets Inc. bought a new position in shares of Clorox during the 1st quarter valued at about $1,054,000. Allianz Asset Management GmbH increased its position in shares of Clorox by 7.3% during the 1st quarter. Allianz Asset Management GmbH now owns 27,271 shares of the company’s stock valued at $3,630,000 after purchasing an additional 1,848 shares during the last quarter. Mount Yale Investment Advisors LLC bought a new position in shares of Clorox during the 1st quarter valued at about $280,000. Finally, DnB Asset Management AS increased its position in shares of Clorox by 3.8% during the 2nd quarter. DnB Asset Management AS now owns 16,540 shares of the company’s stock valued at $2,237,000 after purchasing an additional 600 shares during the last quarter. Hedge funds and other institutional investors own 78.36% of the company’s stock.

In other Clorox news, EVP Laura Stein sold 12,880 shares of the stock in a transaction that occurred on Friday, August 31st. The stock was sold at an average price of $144.10, for a total value of $1,856,008.00. Following the completion of the sale, the executive vice president now owns 74,483 shares in the company, valued at approximately $10,733,000.30. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Dawn C. Willoughby sold 3,387 shares of the stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total value of $501,309.87. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,268 shares of company stock valued at $4,196,686. Company insiders own 1.40% of the company’s stock.



CLX opened at $147.82 on Friday. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.67 and a current ratio of 1.09. Clorox Co has a 1 year low of $113.57 and a 1 year high of $155.23. The company has a market cap of $19.36 billion, a P/E ratio of 26.50, a P/E/G ratio of 3.62 and a beta of 0.36.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.08. Clorox had a return on equity of 103.18% and a net margin of 13.44%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.72 billion. During the same period last year, the company earned $1.53 EPS. Clorox’s revenue for the quarter was up 2.7% compared to the same quarter last year. Research analysts forecast that Clorox Co will post 6.41 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Wednesday, October 31st will be issued a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 2.60%. The ex-dividend date is Tuesday, October 30th. Clorox’s dividend payout ratio (DPR) is currently 61.34%.

CLX has been the topic of several recent research reports. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective on the stock in a research report on Wednesday, October 3rd. Argus upgraded Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a research report on Tuesday, September 25th. UBS Group assumed coverage on Clorox in a research report on Wednesday, July 18th. They set a “sell” rating and a $110.00 price target on the stock. Bank of America raised their price target on Clorox from $130.00 to $140.00 and gave the stock a “neutral” rating in a research report on Monday, July 16th. Finally, Deutsche Bank lowered Clorox from a “hold” rating to a “sell” rating and set a $123.00 price target on the stock. in a research report on Wednesday, October 10th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company’s stock. Clorox has a consensus rating of “Hold” and a consensus target price of $138.29.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Google Finance Portfolio Tips and Tricks

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply